Cantel Launches New Medical Face Mask to Address Issue of Fit
Cantel Medical Corp. announces the launch of a new design of medical face masks, the SecureFit series by Crosstex International, a Cantel subsidiary. The SecureFit series of masks addresses scientific research that points to poorly fitting masks as a major hindrance to their effectiveness. Medical face masks are often loose-fitting because of the wide variability of facial features of those who wear them. SecureFit earloop medical face masks' patent-pending design enables wearers to quickly and easily adjust the mask for a tighter, customized fit.
A study published in the September 2010 issue of the American Journal of Infection Control quantified the ability of medical face masks to minimize the spread of infection. The study, "Quantifying Exposure Risk and Mask Protection," found that a tighter-fitting mask may offer as much as 100-fold greater infection control benefit than standard, loose-fitting masks.
Gary Steinberg, CEO of Crosstex International, says, "This is among many scientific studies that clearly point to the importance of mask fit in reducing exposure to infectious particles. Masks are intended to protect against the spread of harmful infectious diseases. If they don't fit properly, you're rolling out a red carpet for dangerous infectious material to bypass the mask."
"There is increased attention on respiratory-transmitted infectious disease, both from a cost standpoint for healthcare institutions, as well as from a public health perspective, and the literature now shows that simple medical face masks can play a significant role in addressing both," says Andy Krakauer, CEO of Cantel Medical Corp. "Crosstex's continued research and innovation in this area, and specifically, the SecureFit series of masks, enables us to bring differentiated solutions to broader healthcare and public health markets."
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
